Of 166 Bacteroides fragilis isolates, 26.2% of 103 isolates from blood and 20.6% of 63 extraintestinal isolates harbored the fragilysin gene (difference not statistically significant). Clinical characteristics and evolution were comparable in patients with B. fragilis bacteremia with or without this enterotoxin. Fragilysin seems not to be an important virulence factor in B. fragilis disease.
tidious anaerobe agar (LAB M, Bury, Lancashire, United Kingdom) with 5% horse blood (FAS blood agar) incubated in anaerobic atmosphere but not in 5% CO 2 or in air, morphology on Gram stain, good growth on Bacteroides bile esculin medium with hydrolysis of esculin, resistance to kanamycin, negative indole test, absence of fermentation of trehalose, arabinose, rhamnose, and salicin, and positive fermentation of sucrose. For detection of the fragilysin gene, single colonies of cultures of one glass bead were seeded on FAS blood agar and incubated anaerobically. After a visual check of the culture for purity, a few colonies were suspended in TE buffer (10 mM Tris.HCl, 1 mM EDTA [pH 8.0]), vortexed, heated for 10 min at 100°C, and used directly for the PCR. Primers GBF 101 (5Ј-GAGCCGAAGACGGTGTATGT-3Ј) and GBF 110 (5Ј-T CCCACTGGCTTCAAAATCCGAAGC-3Ј) (5) were used. The expected PCR product was a fragment of 358 bp. B. fragilis strains ATCC 4299 and ATCC 4302 were used, respectively, as positive and negative controls. As an inhibition control, the presence of a 16S rRNA gene fragment was demonstrated on all bacterial DNA samples by an amplification reaction using the primers PSL (AGGATTAGATACCCTGGTAGTCCA) and PSR (ACTTAACCCAACATCTCACGACAC) (1) . The amplifications were performed in a 50-l reaction mixture containing 1ϫ reaction buffer II, 1.5 mM MgCl 2, 200 mM deoxynucleoside triphosphates, 1 M (each) primer, 1 U of TaqDNA polymerase (Applied Biosystems), and 1 l of bac- (2, 16) . The proportion of gene-positive strains was higher for blood isolates (26.2%) than for the other extraintestinal isolates (20.6%). However, this difference was not statistically significant (chi-square test). Furthermore, in extraintestinal isolates, the percentages of gene-positive strains did not differ according to isolation site, as shown in Table 1 . Three studies compared the prevalences of fragilysin-producing B. fragilis among blood isolates and other extraintestinal isolates and found it higher among blood isolates. However, in two studies as well as in our study, the difference was statistically not significant (2, 15) , while only in the study of Kato et al. (5) did the difference reach statistical significance.
We also compared the presence of the fragilysin gene in blood isolates with the clinical presentation. For 69 of the 103 bacteremia patients, including 20 with a fragilysin-positive isolate (29%) and 49 with fragilysin-negative isolate (71%), complete medical records were available. The parameters presented in Table 2 were reviewed. Qualitative parameters were analyzed by using the chi-square test, and quantitative parameters were analyzed by using the Student's t test: no significant difference was seen between the two groups.
We conclude that fragilysin production does not seem to be a virulence factor playing an important role in bacteremia or leading to more-severe disease.
(This work was presented at the 3rd World Congress on Anaerobic Bacteria and Infections, Glasgow, Scotland, 7 to 9 May 2003.) 
